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Glutathione biosynthesis is mediated consecutively by
two mechanistically related ligases, g -glutamylcysteine
synthetase (g -GCase, EC 6.3.2.2) and glutathione synthetase
(EC 6.3.2.3).  The design and synthesis of specific inhibitors
of these physiologically important enzymes are of critical
importance for the development of therapeutic agents as well
as for use as mechanistic and physiological probes in
glutathione metabolism (1).  Following the success in
determining the three dimensional structure of glutathione
synthetase (2) and in developing and characterizing a specific
inhibitor of this enzyme (3), we started the program for the
design and synthesis of transition-state analogue inhibitors of
g -GCase, which is a physiologically more relevant enzyme
regulating the glutathione biosynthesis.  The reaction
catalyzed by g -GCS is thought to proceed via the initial
formation of an acyl phosphate intermediate followed by
nucleophilic attack of cysteine to yield g -Glu-Cys, ADP and
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On the basis of the proposed reaction mechanisms of g -glutamylcysteine synthetase, tetrahedral phosphinic
acid- and sulfoximine-based compounds 1 and 2 were synthesized  and evaluated as inhibitors of E. coli g -
glutamylcysteine synthetase.  Both compounds inactivated the enzyme in a time-dependent manner with an
overall inhibition constant Ki of 4.95 and 0.39 m M, respectively.  The enzyme inactivation was observed
only when  ATP was present, suggesting that the inhibitors are phosphorylated in the enzyme active site,
serving as a mechanism-based inactivator.  The inhibition potency was 10 and 100 times, respectively,
higher than L-buthionine-SR-sulfoximine, a well known inhibitor of this enzyme.  In particular, the
sulfoximine 2 served as an almost irreversible enzyme inactivator with a very slow regain of enzyme
activity (t 1/2 = 3.9 day).  This compound may find a potential use as chemotherapeutic agent.
 
MOLECULAR BIOFUNCTION ¾ Functional Molecular Conversion¾
Scope of research
Our research aims are to elucidate structure-function relationships of biocatalysts in combination with organic
chemistry, molecular biology and X-ray crystallographic technique, and to design and generate a novel biocatalysts
for use as a tailor-made catalyst for organic reactions.  Major subjects are (1) X-Ray diffraction analysis of asparagine
synthetase, (2) Design and synthesis of transition-state analogue inhibitors of ATP-dependent synthetases, (3) Time-
resolved X-ray crystallographic study of glutathione synthetase, (4) Characterization of an activation protein of
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inorganic phosphate.  According to this proposed reaction
mechanism, we designed the phosphinic acid- and
sulfoximine-based transition-state analogues 1 and 2, in which
the g -carboxyl group of L-Glu was replaced by tetrahedral
phosphorus and sulfur atom, respectively, and the attacking
cysteine moiety was mimicked by a -ethylpropionic acid.
Diastereomeric mixture of 1 and 2 were synthesized from a
vinylglycine derivative and homocystine, respectively (4).
Both phosphinate 1 and sulfoximine 2 were found to serve
as potent inactivators of E. coli g -GCS.  Treatment of g -GCS
with varying concentration of 1 or 2 in the presence of ATP
caused a time-dependent inactivation of the enzyme (Figure
1).
The shape of the progress curves represents a typical slow
binding inhibition as observed with the inhibition of
glutathione synthetase by a phosphinic acid transition-state
analogue (3).  Table 1 depicts the extent of inhibition, the
second order rate constants for time-dependent inhibition
(kinact/Ki), and the overall dissociation constants (Ki*)
obtained from the steady-state reaction rates after the binding
equilibrium was reached.  For comparison, the inhibition by
sulfone 3 and L-buthionine-SR-sulfoximine (L-BSO), a well
known inhibitor of this enzyme (5), was also examined.
The overall binding of phosphinate 1 and sulfoximine 2 is
one and two orders of magnitude greater than that of L-BSO,
respectively.  In particular, sulfoximine 2 acted as an
extremely powerful inactivator:  although the sulfoximine 2 is
a mixture of eight diastereomers, it inhibited g -GCS about 126
times more effectively than did L-BSO.  Assuming that the
sulfoximine 2 contains equal amounts of diastereomers and
only one stereoisomer inhibits the enzyme, it could be more
than 500 times as effective as an active diastereomer of L-
BSO.  Both phosphinate 1 and sulfoximine 2 required ATP
for enzyme inactivation: Non-hydrolyzable ATP analogue
such as 5'-adenylylimidodiphosphate (AMPPNP) failed to
cause the inactivation of the enzyme, suggesting a mechanistic
scheme involving phosphorylation of the inhibitors by ATP
within the enzyme active site (3, 5).  This is also supported by
the fact that sulfone 3 served as a simple reversible inhibitor.
Although sulfone 3 did not cause ATP-dependent inactivation
of the enzyme, its inhibition potency was more than five times
higher than that of L-BSO as measured by the inhibition
constant.  The difference is still underestimated because the
initial inhibition constant of sulfone 3 (Ki = 9.2 m M) is
compared with the overall inhibition constant of L-BSO (Ki* =
49m M) where the ATP-dependent tight binding equilibrium
was established.
Another criterion relevant to inhibitor potency is the
duration of enzyme inactivation.  We therefore measured the
extent of recovery of enzyme activity upon 1000-fold dilution
after the enzyme was completely inactivated with sufficient
concentrations of 1 or 2 and ATP.  Under a standard assay
condition, no regain of enzyme activity was observed with
sulfoximine 2, whereas a significant enzyme reactivation (t1/2
< 1 min) was noted with phosphinate 1.  Although the
inhibition by sulfoximine 2 was virtually irreversible within
the time scale of assay, a very slow regain of enzyme activity
was observed (t 1/2 = 3.9 day) when the inactivated enzyme
was gel filtered and incubated in the absence of ATP.  Under
the same conditions, the enzyme inactivated by L-BSO
regained almost 40% of activity immediately after gel
filtration.  Thus, the inhibition potency of sulfoximine 2 is
much higher than L-BSO in terms of both binding affinity and
duration of enzyme inactivation.  The sulfoximine 2 is a
promising candidate for use as a physiological probe and
chemotherapeutic agent to cause a long-lasting glutathione
depletion in the living organisms.
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Figure 1. Progress curves for the inactivation of g -GCS by (a)
phosphinate 1, and (b) sulfoximine 2.  The reaction was initiated by
adding the enzyme to an assay mixture containing L-Glu (0.75 mM),
L-2-aminobutyric acid (150 mM), ATP (1 mM), MgSO4 (10 mM)
and 1 (10-100 m M) or 2 (1-10 m M) in 0.1 M Tris-HCl (pH 7.5) at
37° C.
